teriparatide



teriparatide

S1SS1V2VV2S3SS3E4EE4I5II5Q6QQ6L7LL7M8MM8H9HH9N10NN10L11LL11G12GG12K13KK13H14HH14L15LL15N16NN16S17SS17M18MM18E19EE19R20RR20V21VV21E22EE22W23WW23L24LL24R25RR25K26KK26K27KK27L28LL28Q29QQ29D30DD30V31VV31H32HH32N33NN33F34FF34

SMILES None
InChIKey OGBMKVWORPGQRR-UMXFMPSGSA-N
Sequence SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections

Structure pdb 7VVN 7VVK 7VVL 8HA0 8HAO
Ligand site mutations PTH1 PTH2

No bioactivity data available.

teriparatide

S1SS1V2VV2S3SS3E4EE4I5II5Q6QQ6L7LL7M8MM8H9HH9N10NN10L11LL11G12GG12K13KK13H14HH14L15LL15N16NN16S17SS17M18MM18E19EE19R20RR20V21VV21E22EE22W23WW23L24LL24R25RR25K26KK26K27KK27L28LL28Q29QQ29D30DD30V31VV31H32HH32N33NN33F34FF34

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 6
Phase III 3
Phase IV 2

Database connections

Structure pdb 7VVN 7VVK 7VVL 8HA0 8HAO
Ligand site mutations PTH1 PTH2

Sankey plot

Drug Information